Drowsy now, I stubbornly gazed at the light above me. I fidgeted. Blinked my heavy eyelids open. I talked. About what, I ...
Donald Trump is reportedly considering easing federal restrictions on marijuana as early as Monday, and cannabis industry ...
Following a pressure campaign from anti-abortion groups, Makary and Health and Human Services Secretary Robert F. Kennedy Jr.
Lay your packing woes to rest. Shop my must-have travel essentials that will make your life so much easier (thank me later).
Florida Attorney General James Uthmeier told Fox News Digital on Friday it is "blatantly false" to claim that a popular abortion-inducing drug now under federal review is "safer than Tylenol," ...
I’m a forgetful person, and when it comes to mundane tasks, like watering plants or taking any doctor-prescribed medicine, I always have more pressing things to think about (to the chagrin of my ...
Florida Attorney General James Uthmeier is suing Planned Parenthood, accusing the group of “lying to” women about the safety of abortion medication. The lawsuit marks at least the second time that ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...
This is read by an automated voice. Please report any issues or inconsistencies here. Kimberly-Clark is acquiring Kenvue for $48.7 billion, combining Tylenol, Kleenex, Band-Aid and Listerine into a ...
Kimberly-Clark on Monday said it is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, combining the Huggies manufacturer with the owner of Aveeno and Band-Aid. Kenvue ...
Huggies maker Kimberly-Clark announced Monday it will buy Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating a massive consumer products conglomerate. The merger is the latest in a ...
Kenvue KVUE0.06%increase; green up pointing triangle plans to name advertising veteran Jon Halvorson as its chief marketing officer, as the company faces a public-relations crisis over claims that use ...